Valtoco — CareFirst (Caremark)
acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from the patient’s usual seizure pattern in patients with epilepsy
Initial criteria
- Drug is being prescribed for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from the patient’s usual seizure pattern in a patient with epilepsy
- Patient age is ≥ 2 years
Approval duration
12 months